Skip to content

Study of Advance Care Planning by Acute Care Physician (ACP-2 study)

Study of Advance Care Planning by Acute Care Physician (ACP-2 study) - ACP-2 study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050619
Enrollment
600
Registered
2023-08-31
Start date
2023-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency Medicine

Interventions

None listed

Sponsors

Niigata University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients admitted to each facility on an emergency basis and treated primarily by acute care physicians

Exclusion criteria

Exclusion criteria: Patients who declined to participate in the study through an opt-out format Patients deemed inappropriate by the attending physician

Design outcomes

Primary

MeasureTime frame
(1) Whether or not ACP is performed during emergency department admission. 1-1. Rate the following on a 4-point scale (If ACP was performed) Has the surrogate decision maker been identified? Has the patient's understanding of the disease been confirmed? Have treatment goals been shared? Has the patient's medical record been adequately documented? 1-2. Related items (advance directives, DNAR, DNI, BSC, etc.) (2) Questionnaire regarding inpatient care to be administered to patients 2-1. Has there been adequate discussion between the patient and the health care provider? 2-2. Were the patient's own values shared with the medical staff? 2-3. Were the patient's wishes reflected in the treatment? 2-4. Does the patient feel satisfied with the treatment?

Countries

Japan

Contacts

Public ContactNatsuo Kamimura

Niigata Univercity Medical and Dental Hospirtal Advanced Emergency and Critical Care Center

8788kanatsu@gmail.com025-223-6161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026